about
MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25)Therapy-related acute myeloid leukemia with eosinophilia, basophilia, t(4;14)(q12;q24) and PDGFRA rearrangement: a case report and review of the literatureTwo transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemiaEvolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.[Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.Aberrant expression of CD19 and CD43 in a patient with therapy-related acute myeloid leukemia and a history of mantle cell lymphoma.Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of Myelodysplasia.The DNA double-strand break response is abnormal in myeloblasts from patients with therapy-related acute myeloid leukemia.Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer.Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation.Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes.Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.Therapy-related acute myeloid leukemia and myelodysplasia after successful treatment of acute promyelocytic leukemia.Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes.Therapy related acute myeloid leukemia with t(10:16): a rare entityThe co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case reportTherapy related acute myeloid leukemia in breast cancer survivors, a population-based study.Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancerTherapy-related acute myeloid leukemia in patients with lymphoma: A report of four cases and review of the literature.MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).Therapy-related acute myeloid leukemia in a primary pulmonary leiomyosarcoma patient with skin metastasis.MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.A new subtype of MLL-SEPT2 fusion transcript in therapy-related acute myeloid leukemia with t(2;11)(q37;q23): a case report and literature review.Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia.Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia.Gingival enlargement as an early diagnostic indicator in therapy-related acute myeloid leukemia: A rare case report and review of literatureTherapy-related acute myeloid leukemia with 11q23 abnormality coexisting with refractory metastatic Ewing sarcoma: report of a case and review of the literature.Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies.Therapy-related acute myeloid leukemia with favorable cytogenetics: still favorable?Novel Therapeutics for Therapy-Related Acute Myeloid Leukemia: 2014.Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer.Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma.Circulating Breast Carcinoma Cells Mimicking Therapy-Related Acute Myeloid Leukemia.Therapy-related Acute Myeloid Leukemia after the Long-term Administration of Low-dose Etoposide for Chronic-type Adult T-cell Leukemia-lymphoma: A Case Report and Literature Review.Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome.Translocation (11;11)(p13- p15;q23) in a child with therapy-related acute myeloid leukemia following chemotherapy with DNA-topoisomerase II inhibitors for Langerhans cell histiocytosis.Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
P921
Q22009898-DEFA40FB-C051-4BA9-9D8D-08EF7979CB56Q26801945-5BBC3E5E-D7E2-44C0-BF20-6E24B8C8BB96Q28305210-D5B21516-6854-4CA5-99BB-AA7355A93F16Q30538788-D7CEAF9E-3067-4270-8FAA-B1A78E758EC3Q33343332-BC9CB3A3-DFA7-4ED4-9A90-FAD84CA309A6Q33366338-BCEBFAFA-00D2-4A60-BDA7-0202E9F42B45Q33385391-081A03D5-6A65-441E-8525-C384D67210BFQ33435191-2CC73F6A-FA60-47F8-9AE4-0F6C56254364Q33717681-274FC374-C988-4A6A-9D42-990585C0E5FCQ33724657-FFB92B74-DF2F-4DCB-877F-E1DAFDD6884AQ33927551-1FBEE8BB-A6B2-4078-B4AA-7255AB7653D6Q34264317-78058EC4-0589-4C87-BF6A-8893F7B7F029Q34380411-6BDA433C-E0B7-4195-8DAB-202EAC5531C3Q34630770-9C3071B8-A8E0-4D47-8EB9-B0BF40FB7381Q35229164-FC477492-37D6-4A89-BA37-3ACAA781F305Q35720059-B2B01557-4007-4FDE-9257-A1354DA0EEC9Q35892130-A05F1B1E-FB09-490F-9400-4AD40F23ECE4Q36103987-11EEEBBB-88D2-45AA-A03A-A6FFA5331210Q36274109-268931E2-4416-4B8C-AC53-477703826993Q36297677-BE1C27CB-2465-4C05-9D17-BEA2C6B47891Q36335336-3FF78D3B-1810-42A8-BDB1-9E8E9D0143C1Q36556977-BDD5FA95-1A38-4859-8140-5266C78529CCQ36654700-83461225-A96C-4007-A73B-2D3D20CD002CQ36787577-5B52F4CA-03B7-4795-A313-29A55C634DFCQ36851747-9EBF9DFC-ED42-47B5-A605-DAECAB1E0A0EQ36973276-887EBB64-F72A-4A02-A074-B204CD716A41Q37002149-8BA59BDD-66A5-4167-925C-9DB3FE3846FFQ37020294-EB87AE8E-D68C-4294-A790-3A1EE4B20003Q37635129-39499013-77E5-4644-B9F0-A83C63D4076DQ37699158-217A1EC0-E9CA-4BF5-96A1-B5C13548731FQ38048987-F6DDD7B1-ACB2-449D-A111-BD1747CF9215Q38571469-33F5E05B-678C-4F0C-A4AD-DC53CADBC2DBQ38603374-C8F7563E-509F-4707-8F1C-25496FC11D55Q38860992-C6F6BE51-C63F-4611-84C2-010502BFE3D4Q38932566-980185C5-A1A5-4986-B30E-C1C000B640CDQ39440364-E511FFC3-EA8B-46E9-86F8-97E86A613B3BQ40390037-6807857F-512F-44BB-B826-9BB7B01B3317Q40580381-D1160B64-67AD-4E55-BC32-18A7EFDB6F60Q40761813-7D19392C-82DA-416A-AE58-499042134123Q40782576-77E2715B-2CF1-402A-8D9F-11B41CCFFF7A
P921
name
therapy-related acute myeloid leukemia
@en
type
label
therapy-related acute myeloid leukemia
@en
prefLabel
therapy-related acute myeloid leukemia
@en